Imiquimod's efficacy is variable for basal cell carcinoma. (Good Results in Superficial Lesions).

Publication: Skin & Allergy News

Publication Date: 01-JAN-02

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2002 International Medical News Group

LAS VEGAS -- Do not expect that every small, basal cell carcinoma will respond to treatment with imiquimod 5% cream, Dr. Todd S. Anhalt said at a seminar sponsored by the Skin Disease Education Foundation.

"I have had three or four patients with small, presumably easy to treat basal cells that were still there after 16 weeks,"...

Read the full article for free courtesy of your local library.